{ "cik": 1802665, "cik_padded": "0001802665", "entityName": "Harmony Biosciences Holdings, Inc.", "fiscal_years": [ { "accn": "0001104659-26-018859", "filed": "2026-02-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 310000.0, "cash": 752502000.0, "cost_of_revenue": 198342000.0, "eps_diluted": 2.71, "free_cash_flow": 347889000.0, "gross_profit": 670111000.0, "net_income": 158687000.0, "operating_cash_flow": 348199000.0, "operating_income": 208469000.0, "revenue": 868453000.0, "stockholders_equity": 870218000.0, "total_assets": 1271631000.0, "total_liabilities": 401413000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.771614583633196, "leverage": 0.46127866810385443, "net_margin": 0.18272376282884623, "operating_margin": 0.2400463813240325, "revenue_growth_yoy": 0.21507162105062863, "roa_avg2y": 0.13976117113074465, "roa_period_end": 0.12479013172846526, "roe_avg2y": 0.20751902904000527, "roe_period_end": 0.1823531574846763 } }, { "accn": "0001104659-26-018859", "filed": "2026-02-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1153000.0, "cash": 453001000.0, "cost_of_revenue": 156815000.0, "eps_diluted": 2.51, "free_cash_flow": 218668000.0, "gross_profit": 557919000.0, "net_income": 145493000.0, "operating_cash_flow": 219821000.0, "operating_income": 190826000.0, "revenue": 714734000.0, "stockholders_equity": 659155000.0, "total_assets": 999200000.0, "total_liabilities": 340045000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.780596697512641, "leverage": 0.5158801799273312, "net_margin": 0.2035624442100138, "operating_margin": 0.26698883780539334, "revenue_growth_yoy": 0.22801887213885386, "roa_avg2y": 0.16070821054119852, "roa_period_end": 0.14560948759007206, "roe_avg2y": 0.2583907784685303, "roe_period_end": 0.22072653624716496 } }, { "accn": "0001558370-25-001441", "filed": "2026-02-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 312000.0, "cash": 311660000.0, "cost_of_revenue": 121236000.0, "eps_diluted": 2.13, "free_cash_flow": 219075000.0, "gross_profit": 460786000.0, "net_income": 128853000.0, "operating_cash_flow": 219387000.0, "operating_income": 192030000.0, "revenue": 582022000.0, "stockholders_equity": 466992000.0, "total_assets": 811448000.0, "total_liabilities": 344456000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7916985955857339, "leverage": 0.7376057833967177, "net_margin": 0.22138853857757954, "operating_margin": 0.32993598180137523, "revenue_growth_yoy": 0.32925740256477604, "roa_avg2y": 0.17350223992437983, "roa_period_end": 0.15879390915992153, "roe_avg2y": 0.29627168527183473, "roe_period_end": 0.27592121492445265 } }, { "accn": "0001558370-25-001441", "filed": "2026-02-24", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 172000.0, "cash": 243784000.0, "cost_of_revenue": 83481000.0, "eps_diluted": 2.97, "free_cash_flow": 144294000.0, "gross_profit": 354374000.0, "net_income": 181468000.0, "operating_cash_flow": 144466000.0, "operating_income": 120186000.0, "revenue": 437855000.0, "stockholders_equity": 402838000.0, "total_assets": 673870000.0, "total_liabilities": 271032000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8093409918808738, "leverage": 0.6728064383201188, "net_margin": 0.4144477052905643, "operating_margin": 0.2744881296319558, "revenue_growth_yoy": 0.43352213200628603, "roa_avg2y": 0.3277627915503566, "roa_period_end": 0.2692922967337914, "roe_avg2y": 0.6158294377656551, "roe_period_end": 0.4504738877662981 } }, { "accn": "0001558370-25-001441", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 298000.0, "cash": 234309000.0, "cost_of_revenue": 55518000.0, "eps_diluted": 0.58, "free_cash_flow": 98259000.0, "gross_profit": 249922000.0, "net_income": 34597000.0, "operating_cash_flow": 98557000.0, "operating_income": 87528000.0, "revenue": 305440000.0, "stockholders_equity": 186507000.0, "total_assets": 433443000.0, "total_liabilities": 246936000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8182359874279728, "leverage": 1.324003924785665, "net_margin": 0.1132693818753274, "operating_margin": 0.2865636458878994, "revenue_growth_yoy": 0.912083234215172, "roa_avg2y": 0.08040980015502308, "roa_period_end": 0.07981903041461046, "roe_avg2y": 0.24390966099962283, "roe_period_end": 0.18549973995614105 } }, { "accn": "0001558370-24-001466", "filed": "2024-02-22", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2000.0, "cash": 228631000.0, "cost_of_revenue": 27738000.0, "eps_diluted": -2.48, "free_cash_flow": -2987000.0, "gross_profit": 132004000.0, "net_income": -36944000.0, "operating_cash_flow": -2985000.0, "operating_income": 16986000.0, "revenue": 159742000.0, "stockholders_equity": 97180000.0, "total_assets": 427074000.0, "total_liabilities": 329894000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8263575014711222, "leverage": 3.394669685120395, "net_margin": -0.23127292759574813, "operating_margin": 0.10633396351616982, "revenue_growth_yoy": 25.645871559633026, "roa_avg2y": -0.13842484782971165, "roa_period_end": -0.08650491483911454, "roe_avg2y": 0.2268716109579283, "roe_period_end": -0.38016052685737806 } }, { "accn": "0001558370-23-001574", "filed": "2023-02-21", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 149000.0, "cash": 24457000.0, "cost_of_revenue": 1577000.0, "eps_diluted": -24.07, "free_cash_flow": -75585000.0, "gross_profit": 4418000.0, "net_income": -151977000.0, "operating_cash_flow": -75436000.0, "operating_income": -145904000.0, "revenue": 5995000.0, "stockholders_equity": -422862000.0, "total_assets": 106703000.0, "total_liabilities": 118288000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.7369474562135112, "roa_period_end": -1.4242992230771394, "roe_avg2y": 0.4567062588744394 } }, { "accn": "0001558370-22-002257", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -242673000.0 }, "period_end": "2018-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001104659-26-018859", "filed": "2026-02-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001802665.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001802665.json" }, "ticker": "HRMY" }